Share
News
-
31 October 2008 /Authorisation and supervision
Control of streptokinase-containing medicinal products
The Danish Medicines Agency's laboratory has tested five different products that contain the active substance streptokinase, which is used for the treatment of blood clots.
-
31 October 2008 /Authorisation and supervision
Control of oral suspensions
The Danish Medicines Agency's laboratory has analysed six different oral suspensions. The control was carried out in response to a complaint about microbiological contamination in one of the products after opening.
-
29 October 2008 /Prices and reimbursement
Reassessment of reimbursement status for medicinal products in ATC group C08CA
The Danish Medicines Agency has assessed the question of the future reimbursement status for medicinal products in ATC group C08CA (dihydropyridine calcium channel blockers) which are used for the treatment of cardiovascular diseases.
-
27 October 2008 /Side effects and trials
Second place isn’t good enough – the Danish Medicines Agency increases its focus on the reporting of adverse drug reactions
Among the European countries, Denmark is only surpassed by France when it comes to gathering the proportionately largest number of reports on side effects from medicine.
-
27 October 2008 /Side effects and trials
EMEA recommends to suspend the licence for the weight-loss product Acomplia® across the EU
The European Medicines Agency (EMEA) has recommended that the licence for Acomplia® from the company Sanofi-Aventis be suspended across the EU. The EMEA's Committee for Medicinal Products for Human Use (CHMP) has assessed that the benefits of the rimonabant-containing Acomplia® no longer outweigh its risks.
-
21 October 2008 /News - miscellaneous
Warning against scare campaign
"EU will ban natural vitamins" and "In the future, you can only buy your vitamins at the pharmacy". These are but two of the scare messages contained in Danish chain mails that thousands of Danes have been receiving over the past few weeks.
-
10 October 2008 /News - miscellaneous
Illegal distribution of electronic cigarettes
Recently, the Danish Medicines Agency has been made aware that a number of electronic cigarettes, and similar products, are being sold illegally, e.g. via the internet. The products are sold under various product names.
-
07 October 2008 /Prices and reimbursement
Executive order on calculation of consumer prices, etc. of medicinal products
On 6 October 2008, a new executive order on price calculation enters into force, repealing executive order no. 270 of 21 March 2007 with the same title.
-
30 August 2007 | Updated 06 October 2008 /Side effects and trials
Consumption and adverse reactions to treatment of attention and hyperactivity disorders in children
The consumption of medicinal products for treatment of ADHD (Attention Deficit/Hyperactivity Disorder) in children has increased significantly over the past years.
